Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Enveloped virus-like particle expression of human cytomegalovirus glycoprotein B antigen induces antibodies with potent and broad neutralizing activity.

Kirchmeier M, Fluckiger AC, Soare C, Bozic J, Ontsouka B, Ahmed T, Diress A, Pereira L, Schödel F, Plotkin S, Dalba C, Klatzmann D, Anderson DE.

Clin Vaccine Immunol. 2014 Feb;21(2):174-80. doi: 10.1128/CVI.00662-13. Epub 2013 Dec 11.

2.

Recombinant retrovirus-derived virus-like particle-based vaccines induce hepatitis C virus-specific cellular and neutralizing immune responses in mice.

Huret C, Desjardins D, Miyalou M, Levacher B, Amadoudji Zin M, Bonduelle O, Combadière B, Dalba C, Klatzmann D, Bellier B.

Vaccine. 2013 Mar 1;31(11):1540-7. doi: 10.1016/j.vaccine.2012.05.025. Epub 2012 May 24.

PMID:
22634300
3.

Down-regulation of CD81 in human cells producing HCV-E1/E2 retroVLPs.

Rodrigues AF, Guerreiro MR, Castro R, Tomás HA, Dalba C, Klatzmann D, Alves PM, Carrondo MJ, Coroadinha AS.

BMC Proc. 2011 Nov 22;5 Suppl 8:P72. doi: 10.1186/1753-6561-5-S8-P72. eCollection 2011. No abstract available.

4.

A prime-boost strategy using virus-like particles pseudotyped for HCV proteins triggers broadly neutralizing antibodies in macaques.

Garrone P, Fluckiger AC, Mangeot PE, Gauthier E, Dupeyrot-Lacas P, Mancip J, Cangialosi A, Du Chéné I, LeGrand R, Mangeot I, Lavillette D, Bellier B, Cosset FL, Tangy F, Klatzmann D, Dalba C.

Sci Transl Med. 2011 Aug 3;3(94):94ra71. doi: 10.1126/scitranslmed.3002330.

5.

Down-regulation of CD81 tetraspanin in human cells producing retroviral-based particles: tailoring vector composition.

Rodrigues AF, Guerreiro MR, Santiago VM, Dalba C, Klatzmann D, Alves PM, Carrondo MJ, Coroadinha AS.

Biotechnol Bioeng. 2011 Nov;108(11):2623-33. doi: 10.1002/bit.23231. Epub 2011 Jun 21.

PMID:
21656710
6.

DNA vaccines expressing retrovirus-like particles are efficient immunogens to induce neutralizing antibodies.

Bellier B, Huret C, Miyalou M, Desjardins D, Frenkiel MP, Despres P, Tangy F, Dalba C, Klatzmann D.

Vaccine. 2009 Sep 25;27(42):5772-80. doi: 10.1016/j.vaccine.2009.07.059. Epub 2009 Aug 3.

PMID:
19656495
7.

Recombinant retrovirus-like particle forming DNA vaccines in prime-boost immunization and their use for hepatitis C virus vaccine development.

Desjardins D, Huret C, Dalba C, Kreppel F, Kochanek S, Cosset FL, Tangy F, Klatzmann D, Bellier B.

J Gene Med. 2009 Apr;11(4):313-25. doi: 10.1002/jgm.1307.

PMID:
19248137
8.

Replication-competent vectors and empty virus-like particles: new retroviral vector designs for cancer gene therapy or vaccines.

Dalba C, Bellier B, Kasahara N, Klatzmann D.

Mol Ther. 2007 Mar;15(3):457-66. Epub 2007 Jan 23. Review.

9.

DNA vaccines encoding retrovirus-based virus-like particles induce efficient immune responses without adjuvant.

Bellier B, Dalba C, Clerc B, Desjardins D, Drury R, Cosset FL, Collins M, Klatzmann D.

Vaccine. 2006 Mar 24;24(14):2643-55. Epub 2005 Dec 5.

PMID:
16481074
10.

Beyond oncolytic virotherapy: replication-competent retrovirus vectors for selective and stable transduction of tumors.

Dalba C, Klatzmann D, Logg CR, Kasahara N.

Curr Gene Ther. 2005 Dec;5(6):655-67. Review.

PMID:
16457654

Supplemental Content

Support Center